Thomas Edward Adams net worth and biography

Thomas Adams Biography and Net Worth

Chief Financial Officer of KORU Medical Systems

Tom joins KORU with medical device industry experience, coming from Integra Life Sciences, where he spent the last 10 years, with his most recent role there as Senior Director of Finance (FP&A). Previous roles included Group Controller/Head of FP&A and Director of Finance (FP&A). Career highlights include establishing the Finance function for a newly created manufacturing division at Integra, which involved creating processes, setting up systems for reporting, management presentations and hiring a strong team. Tom recently led the financial analysis and negotiation to move Integra’s headquarters to Princeton, NJ, which this deal was recently awarded NJ’s 2019 office real estate deal of the year! He earned his Bachelor of Science in Business Administration-Accounting & Finance from Ohio State University. Tom brings extensive expertise and experience in building forecasts, budgets, modeling, and cost accounting that will support decision making and actions to help drive KORU’s growth.

What is Thomas Edward Adams' net worth?: The estimated net worth of Thomas Edward Adams is at least $1.24 million as of May 14th, 2026. Mr. Adams owns 308,147 shares of KORU Medical Systems stock worth more than $1,241,832 as of July 22nd. This net worth evaluation does not reflect any other investments that Mr. Adams may own. Learn More about Thomas Edward Adams' net worth.
How do I contact Thomas Edward Adams?: The corporate mailing address for Mr. Adams and other KORU Medical Systems executives is 24 CARPENTER RD, CHESTER NY, 10918. KORU Medical Systems can also be reached via phone at (845) 469-2042 and via email at [email protected]. Learn More on Thomas Edward Adams' contact information.
Has Thomas Edward Adams been buying or selling shares of KORU Medical Systems?: Thomas Edward Adams has not been actively trading shares of KORU Medical Systems during the past quarter. Most recently, on Thursday, May 14th, Thomas Edward Adams bought 5,500 shares of KORU Medical Systems stock. The stock was acquired at an average cost of $3.86 per share, with a total value of $21,230.00. Following the completion of the transaction, the chief financial officer now directly owns 308,147 shares of the company's stock, valued at $1,189,447.42. Learn More on Thomas Edward Adams' trading history.
Who are KORU Medical Systems' active insiders?: KORU Medical Systems' insider roster includes Thomas Adams (Chief Financial Officer), James Beck (Director), Adam Kalbermatten (President and Chief Executive Officer), Joseph Manko, Jr. (Director), Christopher Pazdan (Chief Operating Officer), and Eric Schiller (Chief Technology Officer). Learn More on KORU Medical Systems' active insiders.
Are insiders buying or selling shares of KORU Medical Systems?: In the last twelve months, KORU Medical Systems insiders bought shares 4 times. They purchased a total of 28,000 shares worth more than $109,430.00. The most recent insider tranaction occured on June, 11th when insider Adam R Kalbermatten bought 12,500 shares worth more than $49,250.00. Insiders at KORU Medical Systems own 18.5% of the company. Learn More about insider trades at KORU Medical Systems.
Information on this page was last updated on 6/11/2026.

Thomas Edward Adams Insider Trading History at KORU Medical Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2026	Buy	5,500	$3.86	$21,230.00	308,147

Thomas Edward Adams Buying and Selling Activity at KORU Medical Systems

KORU Medical Systems Company Overview

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Today's Range

Now: $3.86

$3.83

$4.03

50 Day Range

MA: $4.12

$3.83

$4.60

2 Week Range

Now: $3.86

$3.20

$6.61

Volume

148,768 shs

Average Volume

160,699 shs

Market Capitalization

$177.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41